Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions he has had with manufacturers of drugs for the treatment of AIDS on preventing rises in the prices of such drugs.
There have been no such representations or discussions. The prices of branded medicines are controlled by the 2014 Pharmaceutical Price Regulation Scheme or under the statutory scheme established under the Health Service Branded Medicines (Control of Prices and Supply of Information) (No.2) Regulations 2008 and the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007.